These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6152404)

  • 21. Mu-opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic.
    Hammer RP
    Brain Res; 1990 May; 515(1-2):187-92. PubMed ID: 2162717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
    Maruyama M; Sugino H; Akita K; Hatanaka H
    Brain Res; 1987 Jan; 401(1):14-22. PubMed ID: 2880641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of opioid binding subtypes in the bovine adrenal medulla.
    Bunn SJ; Marley PD; Livett BG
    Neuroscience; 1988 Dec; 27(3):1081-94. PubMed ID: 2855262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.
    Slater P; Cross AJ; Hewitt L; Savage WJ
    J Recept Res; 1989; 9(2):171-80. PubMed ID: 2568485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dog cerebral cortex contains mu-, delta- and kappa-opioid receptors at different densities: apparent lack of evidence for subtypes of the kappa-receptor using selective radioligands.
    Sharif NA; Durie E; Michel AD; Whiting RL
    Brain Res; 1990 Feb; 510(1):108-14. PubMed ID: 2157522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization of opiate receptors and opioid peptides in sequential brain sections.
    Lewis ME; Khachaturian H; Watson SJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1347-50. PubMed ID: 6292628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.
    Schnittler M; Liebmann C; Schrader U; Schulze HP; Neubert K; Repke H
    Biomed Biochim Acta; 1990; 49(4):209-18. PubMed ID: 2169723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats.
    Fadda P; Tronci S; Colombo G; Fratta W
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1296-305. PubMed ID: 10470971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of opioid receptors in cultured neurons.
    Vaysse PJ; Zukin RS; Fields KL; Kessler JA
    J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y; Simon EJ
    J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Types of opioid receptors: relation to antinociception.
    Kosterlitz HW; Paterson SJ
    Philos Trans R Soc Lond B Biol Sci; 1985 Feb; 308(1136):291-7. PubMed ID: 2858883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.
    Richardson A; Demoliou-Mason C; Barnard EA
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10198-202. PubMed ID: 1332034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
    Corbett AD; Paterson SJ; McKnight AT; Magnan J; Kosterlitz HW
    Nature; 1982 Sep; 299(5878):79-81. PubMed ID: 6125893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.